1-225419442-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002296.4(LBR):c.461G>A(p.Ser154Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.816 in 1,609,378 control chromosomes in the GnomAD database, including 543,983 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002296.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LBR | NM_002296.4 | c.461G>A | p.Ser154Asn | missense_variant | 5/14 | ENST00000272163.9 | NP_002287.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LBR | ENST00000272163.9 | c.461G>A | p.Ser154Asn | missense_variant | 5/14 | 1 | NM_002296.4 | ENSP00000272163 | P1 | |
LBR | ENST00000338179.6 | c.461G>A | p.Ser154Asn | missense_variant | 5/14 | 5 | ENSP00000339883 | P1 | ||
LBR | ENST00000425080.1 | c.461G>A | p.Ser154Asn | missense_variant | 5/5 | 3 | ENSP00000388059 | |||
LBR | ENST00000651341.1 | c.461G>A | p.Ser154Asn | missense_variant, NMD_transcript_variant | 5/15 | ENSP00000499114 |
Frequencies
GnomAD3 genomes AF: 0.730 AC: 110920AN: 152030Hom.: 43266 Cov.: 33
GnomAD3 exomes AF: 0.811 AC: 202788AN: 249900Hom.: 84223 AF XY: 0.810 AC XY: 109600AN XY: 135252
GnomAD4 exome AF: 0.825 AC: 1202186AN: 1457230Hom.: 500696 Cov.: 34 AF XY: 0.822 AC XY: 596356AN XY: 725214
GnomAD4 genome AF: 0.729 AC: 110989AN: 152148Hom.: 43287 Cov.: 33 AF XY: 0.732 AC XY: 54406AN XY: 74374
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 09, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 06, 2018 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 80% of total chromosomes in ExAC - |
Greenberg dysplasia Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Reynolds syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Pelger-Huët anomaly Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at